- Home
- CLDX vs TGLS Comparison
CLDX vs TGLS Comparison
Compare CLDX & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | TGLS |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | 1995 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CLDX | TGLS |
|---|---|---|
| Price | $33.91 | $43.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $44.50 | ★ $67.50 |
| AVG Volume (30 Days) | ★ 1.1M | 416.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.42 |
| Revenue | $12,743,000.00 | ★ $370,984,000.00 |
| Revenue This Year | $111.39 | $13.56 |
| Revenue Next Year | $235.85 | $9.67 |
| P/E Ratio | ★ N/A | $13.37 |
| Revenue Growth | ★ 87.78 | 17.98 |
| 52 Week Low | $17.59 | $39.53 |
| 52 Week High | $34.52 | $90.34 |
Technical Indicators
Market Signals| Indicator | CLDX | TGLS |
|---|---|---|
| Relative Strength Index (RSI) | 64.18 | 47.66 |
| Support Level | $24.70 | $40.13 |
| Resistance Level | $34.52 | $47.37 |
| Average True Range (ATR) | 1.56 | 1.99 |
| MACD | 0.11 | 0.40 |
| Stochastic Oscillator | 94.02 | 55.58 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About TGLS Tecnoglass Inc.
Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.